CHRS Research and Charts

CHRS - Coherus BioSciences Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2025-06-30)

Last 0.73	Change ⇓ -0.01 (0.00%)	Volume 1,186,111
	Open 0.74	High 0.74	Low 0.73

8EMA (Daily) 0.74	40EMA (Daily) 0.81	50EMA (Daily) 0.84	STO (Daily) 15.132	MACD Hist (Daily) -0.001
8EMA (Weekly) 0.789	40EMA (Weekly) 1.11	50EMA (Weekly) 1.27	STO (Weekly) 11.234	MACD Hist (Weekly) 0.000


Company Profile
Coherus BioSciences Inc is a United States based biotherapeutics company engaged in developing and commercializing biosimilar therapeutics. The company focuses on process science, analytical characterization, protein production, and clinical-regulatory development. Its pipeline includes Immunology, anti-tumor necrosis factor (Anti-TNF) biosimilar candidates; Ophthalmology biosimilar candidates; and Oncology Biosimilar candidates. Geographically, the group has a business presence in the United States and other countries.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.